alexa Evaluation of ELISA-based sero-diagnosis of dengue fever in travelers.
Microbiology

Microbiology

Journal of Antivirals & Antiretrovirals

Author(s): Schwartz E, Mileguir F, Grossman Z, Mendelson E

Abstract Share this page

Abstract Diagnosis of dengue virus infection in travelers is often based on commercially available ELISA-based serological assays and not on the more difficult and costly procedures of Hemagglutination inhibition (HI), virus isolation or RT-PCR. These standard assays are not quantitative and are designed to diagnose primary and secondary dengue virus infections by testing for IgG and IgM antibodies. However, cross reactivity between various flaviviruses and the fact that most travelers today are prevaccinated against Japanese encelphalitis (JE) and yellow fever (YF) create a potential problem in such diagnosis. Our study was aimed at measuring the extent of false positive diagnosis in prevaccinated travelers which we have assessed by testing for dengue IgG and IgM antibodies in a group of prevaccinated healthy travelers using the PanBio indirect IgG ELISA and IgM capture ELISA kits. The IgM test was negative in all healthy vaccinees, thus, being highly specific. However, the kit had a disadvantage, which was recognized in other travelers clinically ill with dengue fever (DF), in which the IgM response was detected only 4-8 days after onset of the clinical symptoms. The IgG test yielded 11-17 and 15-44\% positives in healthy travelers vaccinated against JE and YF, respectively. We conclude that the specificity of the IgG-ELISA assay in prevaccinated travelers is much lower than in unvaccinated populations. Thus, an IgG-positive results in a vaccinated traveler and IgM negative result during the 1st week of the illness period, are both inconclusive.
This article was published in J Clin Virol and referenced in Journal of Antivirals & Antiretrovirals

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version